Evidence map›Paper›PMID 25866267›Full record

ReviewCurrent topics in medicinal chemistry2015

Peptide aptamers: development and applications.

Sergey Reverdatto, David S Burz, Alexander Shekhtman

Abstract readReview
In one paragraph

Review in Current topics in medicinal chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed.

  1. Design of aptamer peptides for immunomodulation.Journal of enzyme inhibition and medicinal chemistry · 2026
    Article
  2. Peptide Aptamers: Innovative Design and Applications in Pathogen Detection.Chembiochem : a European journal of chemical biology · 2026
    Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Aptamers: precision tools for diagnosing and treating infectious diseases.Frontiers in cellular and infection microbiology · 2024
    Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Single-Cell Analysis in Immuno-Oncology.International journal of molecular sciences · 2023
    Review
  15. Article
  16. Review
  17. Mapping Epitopes by Phage Display.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  18. Review
  19. Article
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sergey Reverdatto
David S Burz
Alexander ShekhtmanDepartment of Chemistry, State University of New York at Albany, 14oo Washington Ave., Albany, NY, USA. ashekhtman@albany.edu.

Funding

Real Time (RT) In-cell NMR technology to study protein interactions in live cellsR01GM085006 · NIGMS · STATE UNIVERSITY OF NEW YORK AT ALBANY · PI SHEKHTMAN, ALEXANDER · 2010 to 2021
$2.4M
NIGMS NIH HHS R01 GM085006NIGMS NIH HHS R01GM08500605
6 · The paper itself

Abstract

Peptide aptamers are small combinatorial proteins that are selected to bind to specific sites on their target molecules. Peptide aptamers consist of short, 5-20 amino acid residues long sequences, typically embedded as a loop within a stable protein scaffold. Various peptide aptamer scaffolds and in vitro and in vivo selection techniques are reviewed with emphasis on specific biomedical, bioimaging, and bioanalytical applications.

Indexed as

Peptide LibraryAntibodiesAptamers, PeptideArmadillo Domain ProteinsDirected Molecular EvolutionGene Expression ProfilingHumansModels, MolecularMolecular ImagingProtein Structure, SecondaryProtein Structure, TertiarySELEX Aptamer TechniqueTwo-Hybrid System TechniquesAntibodiesAptamers, PeptideArmadillo Domain ProteinsPeptide Library

Identifiers

PMID25866267
PMCPMC4428161

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.